Promoted cell proliferation by connexin 30 gene transfection to head-and-neck cancer cell line

Hiroyuki Ozawa1, Hideki Mutai, Tatsuo Matsunaga

  • 1National Institute of Sensory Organs, National Tokyo Medical Center, Meguro-ku, Tokyo 152-8902, Japan. ozakky@cb.mbn.or.jp

Anticancer Research
|June 17, 2009
PubMed
Abstract

Insights

Connexin 30 (Cx30) enhances head and neck cancer cell proliferation. This effect occurs even when Cx30 is not transported to the plasma membrane, suggesting novel mechanisms in tumor growth.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Inconsistent findings exist regarding connexin gene family's role in tumor cell proliferation.
  • Connexins are gap junction proteins involved in cell communication and regulation.

Purpose of the Study:

  • To investigate the specific role of connexin 30 (Cx30) in head and neck cancer cell proliferation.
  • To determine if Cx30's localization (plasma membrane vs. cytoplasm) affects its proliferative influence.

Main Methods:

  • HSC-4 head and neck cancer cells were transfected with vectors expressing full-length Cx30, Cx30 lacking the C-terminal region, or only the C-terminal region.
  • Cell proliferation was assessed using Ki-67 (MIB-1) immunostaining and MIB indices were calculated.

Main Results:

  • Full-length Cx30 localized to the plasma membrane; truncated forms (Cx30-DelC, Cx30-CT) localized to the cytoplasm.
  • HSC-4 cells transfected with Cx30-Full and Cx30-DelC showed significantly increased proliferation compared to controls.
  • Cx30-CT transfection did not significantly alter proliferation rates.

Conclusions:

  • Connexin 30 (Cx30) significantly enhances the proliferation of HSC-4 head and neck cancer cells.
  • Cx30-mediated proliferation can occur independently of its translocation to the plasma membrane, suggesting non-canonical functions.